An audit of outcomes of a series of periampullary carcinomas

European Journal of Surgical Oncology

Volumn 35, Issue 2, 2009, Pages 187-191

  Berberat, P O ^a   Kunzli B M ^a   Gulbinas, A ^a   Ramanauskas, T ^a   Kleeff, J ^a   Muller M W ^a   Wagner, M ^b   Friess, H ^a   Buchler M W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Ampullary; Cholangiocellular; Duodenal prognostic factor; Outcome; Periampullary carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DUODENUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; VATER PAPILLA CARCINOMA;

AGED; AMPULLA OF VATER; BILIARY TRACT SURGICAL PROCEDURES; CARCINOMA; CLINICAL AUDIT; COMMON BILE DUCT NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58149513339     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.01.030     Document Type: Article

References (26)

1. Sarmiento J.M., Nagomey D.M., Sarr M.G., and Farnell M.B. Periampullary cancers: are there differences?. Surg Clin North Am 81 (2001) 543-555
2. Talamini M.A., Moesinger R.C., Pitt H.A., et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 225 (1997) 590-599
3. Birkmeyer J.D., Stukel T.A., Siewers A.E., Goodney P.P., Wennberg D.E., and Lucas F.L. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
4. Beger H.G., Treitschke F., Gansauge F., Harada N., Hiki N., and Mattfeldt T. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 134 (1999) 526-532
5. Bettschart V., Rahman M.Q., Engelken F.J., Madhavan K.K., Parks R.W., and Garden O.J. Presentation, treatment and outcome in patients with ampullary tumours. Br J Surg 91 (2004) 1600-1607
6. Chan C., Herrera M.F., de la Garza L., et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 222 (1995) 632-637
7. Chareton B., Coiffic J., Landen S., Bardaxoglou E., Campion J.P., and Launois B. Diagnosis and therapy for ampullary tumors: 63 cases. World J Surg 20 (1996) 707-712
8. de Castro S.M., Kuhlmann K.F., van Heek N.T., et al. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 8 (2004) 775-784
9. de Castro S.M., van Heek N.T., Kuhlmann K.F., et al. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery 136 (2004) 994-1002
10. Howe J.R., Klimstra D.S., Moccia R.D., Conlon K.C., and Brennan M.F. Factors predictive of survival in ampullary carcinoma. Ann Surg 228 (1998) 87-94
11. Katz M.H., Bouvet M., Al-Refaie W., Gilpin E.A., and Moossa A.R. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Hepatogastroenterology 51 (2004) 842-846
12. Michelassi F., Erroi F., Dawson P.J., et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 210 (1989) 544-554
13. Monson J.R., Donohue J.H., McEntee G.P., et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 126 (1991) 353-357
14. Neoptolemos J.P., Talbot I.C., Carr-Locke D.L., et al. Treatment and outcome in 52 consecutive cases of ampullary carcinoma. Br J Surg 74 (1987) 957-961
15. Yeo C.J., Sohn T.A., Cameron J.L., Hruban R.H., Lillemoe K.D., and Pitt H.A. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227 (1998) 821-831
16. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1999) 613-622
17. Kellum J.M., Clark J., and Miller H.H. Pancreatoduodenectomy for resectable malignant periampullary tumors. Surg Gynecol Obstet 157 (1983) 362-366
18. Martin F.M., Rossi R.L., Dorrucci V., Silverman M.L., and Braasch J.W. Clinical and pathologic correlations in patients with periampullary tumors. Arch Surg 125 (1990) 723-726
19. Schmidt C.M., Powell E.S., Yiannoutsos C.T., et al. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139 (2004) 718-725
20. Trede M., Schwall G., and Saeger H.D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211 (1990) 447-458
21. Wagner M., Redaelli C., Lietz M., Seiler C.A., Friess H., and Buchler M.W. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004) 586-594
22. Yoshida T., Matsumoto T., Sasaki A., Morii Y., Aramaki M., and Kitano S. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 137 (2002) 69-73
23. Fong Y., Blumgart L.H., Lin E., Fortner J.G., and Brennan M.F. Outcome of treatment for distal bile duct cancer. Br J Surg 83 (1996) 1712-1715
24. Bakaeen F.G., Murr M.M., Sarr M.G., et al. What prognostic factors are important in duodenal adenocarcinoma?. Arch Surg 135 (2000) 635-641
25. Yokoyama N., Shirai Y., Wakai T., Nagakura S., Akazawa K., and Hatakeyama K. Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma. World J Surg 29 (2005) 519-523
26. Jarufe N.P., Coldham C., Mayer A.D., Mirza D.F., Buckels J.A., and Bramhall S.R. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 21 (2004) 202-209